European exploitation of biotechnology—do government policies help?

A recent survey of public spending on biotechnology in Europe suggests that money alone cannot stimulate growth of the sector.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1


  1. 1

    Enzing, C. et al. J. Inventory of public biotechnology R&D programmes in Europe, Analytical Report, vol 1. (Office for Official Publications of the European Communities, Luxembourg, 1999). Volumes 2 and 3, containing national reports, will be published in 2000.

  2. 2

    Databases vary widely in their estimates of the number of French biotechnology firms. An emerging consensus indicates there are about 80–100.

  3. 3

    BioResearch Ireland. BioResearch Ireland review '97. Putting Ireland on the biotechnology map. (BRI, Dublin, Ireland, 1998).

Download references


The authors are grateful for support from the EC's BIOTECH programme, which funded this project through contracts BIO4-CT97-2089/2090/2091 and 2346.

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Senker, J., Enzing, C., Joly, P. et al. European exploitation of biotechnology—do government policies help?. Nat Biotechnol 18, 605–608 (2000).

Download citation

Further reading